polygodial has been researched along with cannabidiol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
| Burth, P; Calixto, JB; Dasari, R; De Carvalho, A; De La Chapa, JJ; Dybdal-Hargreaves, NF; Evidente, A; Frolova, LV; Gautier, M; Glass, R; Gonzales, CB; Hague, F; Kälin, RE; Kiss, R; Kornienko, A; Mathieu, V; Medellin, DC; Middleton, KN; Munirathinam, G; Pelly, SC; Pillai, A; Rogelj, S; Rossato, MF; van Otterlo, WA; Volmar, MN | 1 |
1 review(s) available for polygodial and cannabidiol
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |
1 other study(ies) available for polygodial and cannabidiol
| Article | Year |
|---|---|
Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary amines.
Topics: Amines; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytostatic Agents; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Molecular Conformation; Polygonum; Pyrroles; Sesquiterpenes; Structure-Activity Relationship | 2015 |